Tag Info

New answers tagged

1

In response to the above q. many have commented that the process is only limited to Middle Eastern countries....I think the term 'only' will be better substituted by 'mainly', the reason to which , is explained later .... Now, the main clarification lies in the fact that, ....there are more than 600 known antigens besides A and B that characterize ...


2

Which patents are relevant for their device? They currently only have about 27 issued patents (US) Of those patents about 10 of them are related to network/internet/health record/algorithm (so not really about their device) The remaining patents focus on a few areas: sample acquisition (getting the blood drop and handling of it), Patch based technology ...


1

There are other histocompatibility antigens on the surface of blood cells, e.g. A, B, Rh, etc... (There are probably a lot more which change less by person to person, so they have lower effect on the outcome of blood transfusion.) These antigens can be recognized by immune cells as self, that's why they don't destroy them. Before complete differentiation ...


-1

I haven't seen their device and I won't want to see it, I want to first understand the concept better independently. I am not an expert in biology but I have feeling how such device could be done. Noname covers sensitivity and new concept "amplification" raising a new puzzle: is amplification done by analog methods (op-apms), digital methods, dilution ...



Top 50 recent answers are included